DoseMe

DoseMe is a healthcare platform that allows clinicians to estimate patient's drug dosage level based on medical data and laboratory results. Read more

38 Followers on Owler
38 Followers on Owler
38 Followers on Owler
38 Followers on Owler

DoseMe

DoseMe is a healthcare platform that allows clinicians to estimate patient's drug dosage level based on medical data and laboratory results. Read more

Charles Cornish's photo - CEO of DoseMe

CEO

Charles Cornish

CEO Approval Rating

80/100

DOSEME TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Syapse is seen as one of DoseMe's top competitors. Syapse's headquarters is in San Francisco, California, and was founded in 2008. Syapse competes in the Internet Software industry. Syapse generates 381% of DoseMe's revenue.

Translational Software is one of DoseMe's top rivals. Translational Software was founded in 2009, and its headquarters is in Bellevue, Washington. Like DoseMe, Translational Software also works within the Health Care Services industry. Translational Software has 46 fewer employees than DoseMe.

InsightRX is DoseMe's #3 rival. InsightRX is a Private company that was founded in 2015 in San Francisco, California. Like DoseMe, InsightRX also works within the Health Care Services field. Compared to DoseMe, InsightRX has 49 fewer employees.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is $7.4M a good estimate for DoseMe's revenue?

DoseMe Acquisitions

No recent acquisitions found related to DoseMe

DoseMe Funding History

$500K$3.1M

Since DoseMe was founded in 2012, it has participated in 2 rounds of funding. In total DoseMe has raised $3.1M. DoseMe's last funding round was on Aug 2016 for a total of $2.6M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Series A
Aug 2016
$2.6M
-
Seed
Jul 2014
$500K
-

Since DoseMe was founded in 2012, it has participated in 2 rounds of funding. In total DoseMe has raised $3.1M. DoseMe's last funding round was on Aug 2016 for a total of $2.6M

DoseMe Investments

No recent investments found related to DoseMe

DoseMe News

December 4, 2018The Business Journals

Tabula Rasa reaches agreement to buy Australian med tech company

South Jersey medical technology company Tabula Rasa HealthCare (NASDAQ: TRHC) entered into a definiti... See more »
August 29, 2016Geek Time

Brisbane's DoseMe raises $2.6 million to predict perfect drug doses

Able to create personal recommendations off of just one laboratory result, this Australian startup ta... See more »
August 28, 2016Ant Hill

This healthtech start-up that delivers more accurate drug doses has raised a $2.6m Series A round at a $20m valuation

DoseMe, a privately held digital medical solutions provider, recently announced it had closed a $2.6 ... See more »
August 28, 2016MobiHealthNews

Australian digital health startup DoseMe raises $2.6M for precision dosing platform

Australian digital health company DoseMe, which makes a precision dosing tool platform for clinicians... See more »
August 25, 2016HIT Consultant Media

Australian Startup DoseMe Raises $2.6M for Precision Dosing

DoseMe, an Australian digital health startup has raised $2.6 million in Series A funding to expand it... See more »
July 16, 2014BIOSPECTRUM ASIA

Australian firm DoseMe raises $500k

Biospectrum [Read more]... See more »

DoseMe Press Releases

August 22, 2019GlobeNewswire

Bainbridge Health Partners with Tabula Rasa HealthCare's subsidiary DoseMe To Expand Medication Management Capabilities to Health System(s)

MOORESTOWN, N.J., Aug. 22, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc (TRHC) (NASDAQ: TRHC)... See more »
June 13, 2019GlobeNewswire

Houston Methodist Selects Tabula Rasa HealthCare's DoseMe For System-wide Precision Dosing Technology

MOORESTOWN, N.J., June 13, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc.'s (TRHC) (NASDAQ: TR... See more »
June 6, 2019GlobeNewswire

Tabula Rasa HealthCare's DoseMe Signs 3-Year Agreement with Portugal's National Health Service

Recognizes the importance of individualizing medication therapy for every patientRecognizes the impor... See more »
February 1, 2019GlobeNewswire

Tabula Rasa HealthCare's Subsidiary Completes Implementation of Precision Dosing Software for One of the Nation's Leading Healthcare Systems

MOORESTOWN, N.J., Feb. 01, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (TRHC) (NASDAQ: TRHC... See more »
January 7, 2019CentralCharts

Tabula Rasa HealthCare Completes Acquisition of DoseMe

MOORESTOWN, N.J., Jan. 07, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (TRHC) (NASDAQ: TRHC... See more »

Social Media

DoseMe Headquarters

228 Strawbridge Drive

Moorestown, New Jersey08057

1-832-358-3308

Driving Directions »

Trending Companies

DoseMe Summary

ABOUT

Overview

DoseMe is a healthcare platform that allows clinicians to estimate patient's drug dosage level based on medical data and laboratory results. DoseMe was founded in 2012. DoseMe's headquarters is located in Moorestown, New Jersey, USA 08057. It has rais...

CEO

DoseMe's CEO, Charles Cornish, currently has an approval rating of 80%. DoseMe's primary competitors are Syapse, Translational Software & InsightRX.

Website

doseme-rx.com

Frequently Asked Questions about DoseMe

  1. When was DoseMe founded?

    DoseMe was founded in 2012
  2. Who is DoseMe's CEO?

    DoseMe's CEO is Charles Cornish
  3. How much revenue does DoseMe generate?

    DoseMe generates $7.4M in revenue
  4. How much funding does DoseMe have?

    DoseMe has historically raised $3.1M in funding
  1. Where is DoseMe's headquarters?

    DoseMe's headquarters is in Moorestown New Jersey, USA
  2. How many employees does DoseMe have?

    DoseMe has 58 employees
  3. What sector does DoseMe operate in?

    DoseMe is in Health Care Services
  4. Who are DoseMe's competitors?

    DoseMe's top competitors are Syapse, Translational Software, InsightRX